|
2023-05-30 |
2023-05-25 |
A
Achat
|
TANG KEVIN C
Actionnaire important
|
50 000
+1.2%
1,72
86 000 USD
|
50 000
+1.2%
|
1,72
|
86 000 USD
|
|
|
2023-05-24 |
2023-05-22 |
V
Vente
|
GADICKE ANSBERT
Administrateur non-exécutif
Actionnaire important
|
70 170
-18.8%
1,88
131 920 USD
|
70 170
-18.8%
|
1,88
|
131 920 USD
|
|
|
2023-05-24 |
2023-05-22 |
V
Vente
|
MPM ASSET MANAGEMENT LLC
Actionnaire important
|
70 170
-18.8%
1,88
131 920 USD
|
70 170
-18.8%
|
1,88
|
131 920 USD
|
|
|
2023-05-15 |
2023-05-12 |
A
Achat
|
TANG KEVIN C
Actionnaire important
|
6 183
+0.1%
1,95
12 057 USD
|
6 183
+0.1%
|
1,95
|
12 057 USD
|
|
|
2023-05-15 |
2023-05-11 |
A
Achat
|
TANG KEVIN C
Actionnaire important
|
38 765
+0.9%
1,95
75 592 USD
|
38 765
+0.9%
|
1,95
|
75 592 USD
|
|
|
2023-05-10 |
2023-05-10 |
A
Achat
|
TANG KEVIN C
Actionnaire important
|
6 774
+0.2%
1,95
13 209 USD
|
6 774
+0.2%
|
1,95
|
13 209 USD
|
|
|
2023-05-10 |
2023-05-09 |
A
Achat
|
TANG KEVIN C
Actionnaire important
|
20 141
+0.5%
1,95
39 275 USD
|
20 141
+0.5%
|
1,95
|
39 275 USD
|
|
|
2023-05-10 |
2023-05-08 |
A
Achat
|
TANG KEVIN C
Actionnaire important
|
57 073
+1.4%
1,95
111 292 USD
|
57 073
+1.4%
|
1,95
|
111 292 USD
|
|
|
2023-05-05 |
2023-05-05 |
A
Achat
|
TANG KEVIN C
Actionnaire important
|
71 064
+1.7%
1,94
137 864 USD
|
71 064
+1.7%
|
1,94
|
137 864 USD
|
|
|
2023-05-05 |
2023-05-05 |
A
Achat
|
TANG KEVIN C
Actionnaire important
|
95 759
+2.4%
1,90
181 942 USD
|
95 759
+2.4%
|
1,90
|
181 942 USD
|
|
|
2023-05-05 |
2023-05-04 |
A
Achat
|
TANG KEVIN C
Actionnaire important
|
104 241
+2.6%
1,86
193 888 USD
|
104 241
+2.6%
|
1,86
|
193 888 USD
|
|
|
2023-05-05 |
2023-05-03 |
A
Achat
|
TANG KEVIN C
Actionnaire important
|
18 513
+0.5%
1,85
34 249 USD
|
18 513
+0.5%
|
1,85
|
34 249 USD
|
|
|
2022-12-13 |
2022-12-13 |
VP
Vente planifiée
|
Olagunju Peter
Chief Technical Officer
Dirigeant
|
1 659
-6.4%
1,07
1 767 USD
|
1 659
-6.4%
|
1,07
|
1 767 USD
|
|
|
2022-12-13 |
2022-12-13 |
VP
Vente planifiée
|
Menzel Garry E
President and CEO
Administrateur exécutif
|
11 000
-7.3%
1,06
11 682 USD
|
11 000
-7.3%
|
1,06
|
11 682 USD
|
|
|
2022-12-13 |
2022-12-13 |
VP
Vente planifiée
|
Cardama Alfonso Quintas
Chief Medical Officer
Dirigeant
|
4 752
-4.2%
1,06
5 042 USD
|
4 752
-4.2%
|
1,06
|
5 042 USD
|
|
|
2022-12-13 |
2022-12-12 |
VP
Vente planifiée
|
Olagunju Peter
Chief Technical Officer
Dirigeant
|
1 610
-5.9%
1,10
1 766 USD
|
1 610
-5.9%
|
1,10
|
1 766 USD
|
|
|
2022-12-13 |
2022-12-12 |
VP
Vente planifiée
|
Menzel Garry E
President and CEO
Administrateur exécutif
|
10 613
-6.6%
1,10
11 674 USD
|
10 613
-6.6%
|
1,10
|
11 674 USD
|
|
|
2022-12-13 |
2022-12-12 |
VP
Vente planifiée
|
Justice Angela
Chief People Officer
Dirigeant
|
2 963
-5.7%
1,06
3 150 USD
|
2 963
-5.7%
|
1,06
|
3 150 USD
|
|
|
2022-12-13 |
2022-12-12 |
VP
Vente planifiée
|
Justice Angela
Chief People Officer
Dirigeant
|
2 865
-5.2%
1,10
3 149 USD
|
2 865
-5.2%
|
1,10
|
3 149 USD
|
|
|
2022-12-13 |
2022-12-12 |
VP
Vente planifiée
|
Cardama Alfonso Quintas
Chief Medical Officer
Dirigeant
|
4 586
-3.9%
1,10
5 040 USD
|
4 586
-3.9%
|
1,10
|
5 040 USD
|
|
|
2022-12-13 |
2022-12-09 |
VP
Vente planifiée
|
Olagunju Peter
Chief Technical Officer
Dirigeant
|
1 561
-5.4%
1,13
1 765 USD
|
1 561
-5.4%
|
1,13
|
1 765 USD
|
|
|
2022-12-13 |
2022-12-09 |
VP
Vente planifiée
|
Menzel Garry E
President and CEO
Administrateur exécutif
|
10 325
-6.0%
1,13
11 678 USD
|
10 325
-6.0%
|
1,13
|
11 678 USD
|
|
|
2022-12-13 |
2022-12-09 |
VP
Vente planifiée
|
Justice Angela
Chief People Officer
Dirigeant
|
2 792
-4.9%
1,13
3 149 USD
|
2 792
-4.9%
|
1,13
|
3 149 USD
|
|
|
2022-12-13 |
2022-12-09 |
VP
Vente planifiée
|
Cardama Alfonso Quintas
Chief Medical Officer
Dirigeant
|
4 461
-3.6%
1,13
5 041 USD
|
4 461
-3.6%
|
1,13
|
5 041 USD
|
|
|
2022-12-09 |
2022-12-08 |
VP
Vente planifiée
|
Cardama Alfonso Quintas
Chief Medical Officer
Dirigeant
|
4 014
-3.2%
1,26
5 042 USD
|
4 014
-3.2%
|
1,26
|
5 042 USD
|
|
|
2022-12-09 |
2022-12-08 |
VP
Vente planifiée
|
Justice Angela
Chief People Officer
Dirigeant
|
2 511
-4.2%
1,26
3 151 USD
|
2 511
-4.2%
|
1,26
|
3 151 USD
|
|
|
2022-12-09 |
2022-12-08 |
VP
Vente planifiée
|
Menzel Garry E
President and CEO
Administrateur exécutif
|
9 314
-5.2%
1,25
11 680 USD
|
9 314
-5.2%
|
1,25
|
11 680 USD
|
|
|
2022-12-09 |
2022-12-08 |
VP
Vente planifiée
|
Olagunju Peter
Chief Technical Officer
Dirigeant
|
1 410
-4.6%
1,25
1 767 USD
|
1 410
-4.6%
|
1,25
|
1 767 USD
|
|
|
2022-12-09 |
2022-12-07 |
VP
Vente planifiée
|
Cardama Alfonso Quintas
Chief Medical Officer
Dirigeant
|
3 928
-3.0%
1,28
5 040 USD
|
3 928
-3.0%
|
1,28
|
5 040 USD
|
|
|
2022-12-09 |
2022-12-07 |
VP
Vente planifiée
|
Justice Angela
Chief People Officer
Dirigeant
|
2 457
-3.9%
1,28
3 150 USD
|
2 457
-3.9%
|
1,28
|
3 150 USD
|
|
|
2022-12-09 |
2022-12-07 |
VP
Vente planifiée
|
Menzel Garry E
President and CEO
Administrateur exécutif
|
9 111
-4.8%
1,28
11 680 USD
|
9 111
-4.8%
|
1,28
|
11 680 USD
|
|
|
2022-12-09 |
2022-12-07 |
VP
Vente planifiée
|
Olagunju Peter
Chief Technical Officer
Dirigeant
|
1 378
-4.3%
1,28
1 767 USD
|
1 378
-4.3%
|
1,28
|
1 767 USD
|
|
|
2022-12-07 |
2022-12-06 |
VP
Vente planifiée
|
Justice Angela
Chief People Officer
Dirigeant
|
2 361
-3.6%
1,33
3 150 USD
|
2 361
-3.6%
|
1,33
|
3 150 USD
|
|
|
2022-12-07 |
2022-12-06 |
VP
Vente planifiée
|
Olagunju Peter
Chief Technical Officer
Dirigeant
|
1 327
-4.0%
1,33
1 765 USD
|
1 327
-4.0%
|
1,33
|
1 765 USD
|
|
|
2022-12-07 |
2022-12-06 |
VP
Vente planifiée
|
Cardama Alfonso Quintas
Chief Medical Officer
Dirigeant
|
3 778
-2.8%
1,33
5 040 USD
|
3 778
-2.8%
|
1,33
|
5 040 USD
|
|
|
2022-12-07 |
2022-12-06 |
VP
Vente planifiée
|
Menzel Garry E
President and CEO
Administrateur exécutif
|
14 886
-7.3%
1,35
20 081 USD
|
14 886
-7.3%
|
1,35
|
20 081 USD
|
|
|
2022-12-07 |
2022-12-05 |
VP
Vente planifiée
|
Justice Angela
Chief People Officer
Dirigeant
|
2 302
-3.4%
1,37
3 161 USD
|
2 302
-3.4%
|
1,37
|
3 161 USD
|
|
|
2022-12-07 |
2022-12-05 |
VP
Vente planifiée
|
Olagunju Peter
Chief Technical Officer
Dirigeant
|
1 291
-3.8%
1,37
1 766 USD
|
1 291
-3.8%
|
1,37
|
1 766 USD
|
|
|
2022-12-07 |
2022-12-05 |
VP
Vente planifiée
|
Cardama Alfonso Quintas
Chief Medical Officer
Dirigeant
|
3 686
-2.7%
1,37
5 050 USD
|
3 686
-2.7%
|
1,37
|
5 050 USD
|
|
|
2022-12-07 |
2022-12-05 |
VP
Vente planifiée
|
Menzel Garry E
President and CEO
Administrateur exécutif
|
8 530
-4.0%
1,37
11 703 USD
|
8 530
-4.0%
|
1,37
|
11 703 USD
|
|
|
2022-12-05 |
2022-12-02 |
VP
Vente planifiée
|
Justice Angela
Chief People Officer
Dirigeant
|
2 273
-3.3%
1,39
3 162 USD
|
2 273
-3.3%
|
1,39
|
3 162 USD
|
|
|
2022-12-05 |
2022-12-02 |
VP
Vente planifiée
|
Olagunju Peter
Chief Technical Officer
Dirigeant
|
1 273
-3.6%
1,39
1 766 USD
|
1 273
-3.6%
|
1,39
|
1 766 USD
|
|
|
2022-12-05 |
2022-12-02 |
VP
Vente planifiée
|
Menzel Garry E
President & CEO
Administrateur exécutif
|
8 408
-3.8%
1,39
11 687 USD
|
8 408
-3.8%
|
1,39
|
11 687 USD
|
|
|
2022-12-05 |
2022-12-02 |
VP
Vente planifiée
|
Cardama Alfonso Quintas
Chief Medical Officer
Dirigeant
|
3 636
-2.6%
1,39
5 054 USD
|
3 636
-2.6%
|
1,39
|
5 054 USD
|
|
|
2020-12-16 |
2020-12-14 |
VP
Vente planifiée
|
Somaiya Mayur Ian
Chief Financial Officer
Dirigeant
|
2 000
-57.6%
35,00
70 000 USD
|
2 000
-57.6%
|
35,00
|
70 000 USD
|
|
|
2020-11-19 |
2020-11-17 |
VP
Vente planifiée
|
Somaiya Mayur Ian
Chief Financial Officer
Dirigeant
|
1 666
-53.1%
30,00
49 980 USD
|
1 666
-53.1%
|
30,00
|
49 980 USD
|
|
|
2020-11-19 |
2020-11-17 |
VP
Vente planifiée
|
Somaiya Mayur Ian
Chief Financial Officer
Dirigeant
|
2 000
-38.9%
30,00
60 000 USD
|
2 000
-38.9%
|
30,00
|
60 000 USD
|
|
|
2020-11-13 |
2020-11-12 |
VP
Vente planifiée
|
Hofmeister Robert
Chief Scientific Officer
Dirigeant
|
10 002
-20.5%
25,10
251 050 USD
|
10 002
-20.5%
|
25,10
|
251 050 USD
|
|
|
2020-11-13 |
2020-11-12 |
VP
Vente planifiée
|
Hofmeister Robert
Chief Scientific Officer
Dirigeant
|
9 998
-20.5%
25,10
250 950 USD
|
9 998
-20.5%
|
25,10
|
250 950 USD
|
|
|
2020-11-02 |
2020-10-29 |
VP
Vente planifiée
|
Hofmeister Robert
Chief Science Officer
Dirigeant
|
20 000
-34.0%
19,10
382 000 USD
|
20 000
-34.0%
|
19,10
|
382 000 USD
|
|
|
2020-03-27 |
2020-03-20 |
V
Vente
|
Gibson Neil W
Administrateur non-exécutif
|
648
-100.0%
7,94
5 145 USD
|
648
-100.0%
|
7,94
|
5 145 USD
|
|
|
2020-03-27 |
2020-03-19 |
V
Vente
|
Gibson Neil W
Administrateur non-exécutif
|
3 140
-82.9%
7,41
23 267 USD
|
3 140
-82.9%
|
7,41
|
23 267 USD
|
|
|
2020-03-27 |
2020-03-18 |
V
Vente
|
Gibson Neil W
Administrateur non-exécutif
|
3 120
-45.2%
6,83
21 310 USD
|
3 120
-45.2%
|
6,83
|
21 310 USD
|
|
|
2020-03-27 |
2020-03-17 |
V
Vente
|
Gibson Neil W
Administrateur non-exécutif
|
3 009
-30.3%
6,49
19 528 USD
|
3 009
-30.3%
|
6,49
|
19 528 USD
|
|
|
2020-03-27 |
2020-03-16 |
V
Vente
|
Gibson Neil W
Administrateur non-exécutif
|
17 723
-64.1%
6,60
117 043 USD
|
17 723
-64.1%
|
6,60
|
117 043 USD
|
|
|
2020-03-27 |
2020-03-13 |
V
Vente
|
Gibson Neil W
Administrateur non-exécutif
|
52 000
-65.3%
6,52
338 894 USD
|
52 000
-65.3%
|
6,52
|
338 894 USD
|
|
|
2019-12-26 |
2019-12-23 |
VP
Vente planifiée
|
Baeuerle Patrick
Administrateur non-exécutif
|
84 907
-19.5%
15,44
1 310 964 USD
|
84 907
-19.5%
|
15,44
|
1 310 964 USD
|
|
|
2019-12-26 |
2019-12-20 |
VP
Vente planifiée
|
Baeuerle Patrick
Administrateur non-exécutif
|
32 022
-6.8%
15,16
485 454 USD
|
32 022
-6.8%
|
15,16
|
485 454 USD
|
|
|
2019-12-20 |
2019-12-19 |
V
Vente
|
Jovan-Embiricos Morana
Actionnaire important
|
35 323
-18.5%
16,47
581 819 USD
|
35 323
-18.5%
|
16,47
|
581 819 USD
|
|
|
2019-12-20 |
2019-12-19 |
V
Vente
|
Jovan-Embiricos Morana
Actionnaire important
|
6 642
-7.4%
16,47
109 403 USD
|
6 642
-7.4%
|
16,47
|
109 403 USD
|
|
|
2019-12-20 |
2019-12-18 |
V
Vente
|
Jovan-Embiricos Morana
Actionnaire important
|
2 433
-1.3%
17,01
41 376 USD
|
2 433
-1.3%
|
17,01
|
41 376 USD
|
|
|
2019-12-20 |
2019-12-18 |
V
Vente
|
Jovan-Embiricos Morana
Actionnaire important
|
458
-0.5%
17,01
7 789 USD
|
458
-0.5%
|
17,01
|
7 789 USD
|
|
|
2019-12-11 |
2019-12-11 |
V
Vente
|
Jovan-Embiricos Morana
Actionnaire important
|
4 153
-0.3%
17,65
73 311 USD
|
4 153
-0.3%
|
17,65
|
73 311 USD
|
|
|
2019-12-11 |
2019-12-11 |
V
Vente
|
Jovan-Embiricos Morana
Actionnaire important
|
1 054
-0.3%
17,65
18 606 USD
|
1 054
-0.3%
|
17,65
|
18 606 USD
|
|
|
2019-12-11 |
2019-12-11 |
V
Vente
|
Jovan-Embiricos Morana
Actionnaire important
|
1 381
-0.3%
17,65
24 378 USD
|
1 381
-0.3%
|
17,65
|
24 378 USD
|
|
|
2019-12-11 |
2019-12-11 |
V
Vente
|
Jovan-Embiricos Morana
Actionnaire important
|
1 155
-0.3%
17,65
20 389 USD
|
1 155
-0.3%
|
17,65
|
20 389 USD
|
|
|
2019-12-11 |
2019-12-10 |
V
Vente
|
Jovan-Embiricos Morana
Actionnaire important
|
30 475
-2.3%
17,62
537 067 USD
|
30 475
-2.3%
|
17,62
|
537 067 USD
|
|
|
2019-12-11 |
2019-12-10 |
V
Vente
|
Jovan-Embiricos Morana
Actionnaire important
|
7 741
-2.3%
17,62
136 421 USD
|
7 741
-2.3%
|
17,62
|
136 421 USD
|
|
|
2019-12-11 |
2019-12-10 |
V
Vente
|
Jovan-Embiricos Morana
Actionnaire important
|
10 135
-2.3%
17,62
178 611 USD
|
10 135
-2.3%
|
17,62
|
178 611 USD
|
|
|
2019-12-11 |
2019-12-10 |
V
Vente
|
Jovan-Embiricos Morana
Actionnaire important
|
8 479
-2.3%
17,62
149 427 USD
|
8 479
-2.3%
|
17,62
|
149 427 USD
|
|
|
2019-12-11 |
2019-12-09 |
V
Vente
|
Jovan-Embiricos Morana
Actionnaire important
|
75 067
-5.3%
17,65
1 325 015 USD
|
75 067
-5.3%
|
17,65
|
1 325 015 USD
|
|
|
2019-12-11 |
2019-12-09 |
V
Vente
|
Jovan-Embiricos Morana
Actionnaire important
|
19 070
-5.3%
17,65
336 606 USD
|
19 070
-5.3%
|
17,65
|
336 606 USD
|
|
|
2019-12-11 |
2019-12-09 |
V
Vente
|
Jovan-Embiricos Morana
Actionnaire important
|
24 966
-5.3%
17,65
440 677 USD
|
24 966
-5.3%
|
17,65
|
440 677 USD
|
|
|
2019-12-11 |
2019-12-09 |
V
Vente
|
Jovan-Embiricos Morana
Actionnaire important
|
20 886
-5.3%
17,65
368 661 USD
|
20 886
-5.3%
|
17,65
|
368 661 USD
|
|
|
2019-10-24 |
2019-10-22 |
V
Vente
|
Jovan-Embiricos Morana
Actionnaire important
|
2 085
-0.1%
15,16
31 603 USD
|
2 085
-0.1%
|
15,16
|
31 603 USD
|
|
